FlashIntel Founder Yi Shi to Deliver Keynote at SuperAI 2025
Unveiling the Future of Autonomous Voice Agents Transforming Sales and GTM at Scale TOKYO, June 16, 2025 /PRNewswire/ — FlashIntel Japan Co., Ltd. today announced... Read more.
10 Years of VidDay: How a Single Birthday Video Sparked a Global Celebration Platform
NEW YORK, June 16, 2025 /PRNewswire/ — Ten years ago, VidDay began with a single birthday video between friends. Today, it’s a global celebration platform,... Read more.
Just G’s Boutique Transitions to Online Shopping with Exclusive VIP Days in Store
MORGAN HILL, Calif., June 16, 2025 /PRNewswire/ — As spring gives way to the vibrant rays of summer, Just G’s Boutique is adapting to meet customers’... Read more.
Advantum Health CEO Recognized for Leadership in Health IT
Advantum CEO, Tammy Taylor, named by Beckers Hospital Review as one of the top 2025 “Women in Health IT to Know” LOUISVILLE, Ky., June 16, 2025 /PRNewswire/... Read more.
SpotOn Launches ‘GoTo Place’ a Restaurant-First App Built for Independents to Drive Direct Orders, Build Loyalty and Boost Profits
New app gives independent restaurants the advantage of a “super app” without the commissions, complexity or competition, putting operators back in control... Read more.
SynXis Concierge.AI Supercharges Direct Bookings and Guest Engagement with Generative AI
Sabre Hospitality unveils AI integration with SynXis Booking Engine to boost conversions, streamline service, and personalize guest interactions SOUTHLAKE, Texas,... Read more.
ATR and RTX’s Pratt & Whitney Canada collaborate on propulsion technology to advance next-generation regional turboprops
Companies will target continued improvements to aircraft fuel efficiency, durability and operating costs PARIS, June 16, 2025 /PRNewswire/ — ATR and Pratt... Read more.
Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
– Completion of SAD/MAD trial marks advancement toward further clinical development of HT-4253 in Alzheimer’s and other neurodegenerative diseases – LEHI,... Read more.
BrainStorm Announces New Survival Data from Expanded Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn®
NEW YORK, June 16, 2025 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative... Read more.
LS Power Launches New Brand Identity
Building on LS Power’s long history of industry leadership, the new brand reflects the firm’s mission to solve complex energy problems to improve the... Read more.